HJ timeline
Every HJ batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| HJ-2608-C3931 | Semaglutide | 23 Aug 2026 | 2026-Q3 | 4 | 99.34 | 0.72 | 99.78 | +0.44 | |
| HJ-2605-A4196 | Sermorelin | 23 May 2026 | 2026-Q2 | 9 | 99.08 | 1.19 | 99.13 | +0.05 | |
| HJ-2605-D3120 | Tirzepatide | 13 May 2026 | 2026-Q2 | 16 | 98.19 | 1.72 | 98.87 | +0.68 | SHARED BULK |
| HJ-2604-T3574 | Ipamorelin | 04 Apr 2026 | 2026-Q2 | 1 | 98.77 | n<2 | 98.61 | -0.16 | |
| HJ-2603-V4363 | Semax | 16 Mar 2026 | 2026-Q3 | 4 | 99.14 | 0.32 | 99.24 | +0.10 | SHARED BULK |
| HJ-2603-R2258 | GHRP-6 | 02 Mar 2026 | 2026-Q3 | 5 | 99.60 | 1.14 | 99.90 | +0.30 | |
| HJ-2602-X3749 | Semaglutide | 28 Feb 2026 | 2026-Q1 | 1 | 98.57 | n<2 | 99.06 | +0.49 | |
| HJ-2602-W3148 | GHRP-2 | 18 Feb 2026 | 2026-Q2 | 2 | 99.34 | 0.43 | 99.28 | -0.06 | |
| HJ-2601-N2483 | AOD-9604 | 16 Jan 2026 | 2026-Q2 | 7 | 98.85 | 0.88 | 98.98 | +0.13 | |
| HJ-2601-H3602 | TB-500 | 12 Jan 2026 | 2026-Q1 | 2 | 99.60 | 0.67 | 99.90 | +0.30 | |
| HJ-2512-X3528 | GHRP-2 | 17 Dec 2025 | 2026-Q1 | 1 | 99.58 | n<2 | 99.86 | +0.28 | |
| HJ-2511-B3546 | Tirzepatide | 22 Nov 2025 | 2026-Q2 | 1 | 98.83 | n<2 | 99.85 | +1.02 | |
| HJ-2511-P2829 | BPC-157 | 21 Nov 2025 | 2026-Q2 | 2 | 99.78 | 0.16 | 99.88 | +0.10 | |
| HJ-2511-D4010 | Ipamorelin | 19 Nov 2025 | 2025-Q4 | 3 | 99.01 | 0.44 | 99.81 | +0.80 | |
| HJ-2511-V2401 | TB-500 | 16 Nov 2025 | 2026-Q1 | 1 | 99.56 | n<2 | 99.90 | +0.34 | |
| HJ-2511-U3414 | BPC-157 | 14 Nov 2025 | 2026-Q2 | 4 | 98.76 | 0.81 | 99.54 | +0.78 | |
| HJ-2511-L4170 | TB-500 | 14 Nov 2025 | 2026-Q2 | 3 | 99.81 | 0.22 | 99.90 | +0.09 | |
| HJ-2511-L3998 | L-Glutathione (reduced) | 06 Nov 2025 | 2025-Q4 | 1 | 99.02 | n<2 | 99.76 | +0.74 | |
| HJ-2511-F3082 | L-Glutathione (reduced) | 04 Nov 2025 | 2026-Q2 | 5 | 99.93 | 0.34 | 99.90 | -0.03 | |
| HJ-2508-P3416 | Tirzepatide | 30 Aug 2025 | 2026-Q1 | 12 | 98.55 | 1.41 | 99.00 | +0.45 | |
| HJ-2508-C4013 | ARA-290 | 22 Aug 2025 | 2026-Q1 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| HJ-2507-S2872 | PEG-MGF | 30 Jul 2025 | 2025-Q3 | 7 | 98.14 | 1.20 | 99.28 | +1.14 | |
| HJ-2507-P3933 | Semaglutide | 26 Jul 2025 | 2025-Q3 | 8 | 99.23 | 1.42 | 99.80 | +0.57 | |
| HJ-2507-F3983 | Selank | 24 Jul 2025 | 2025-Q3 | 2 | 98.97 | 0.34 | 99.53 | +0.56 | |
| HJ-2507-Y3362 | Semaglutide | 23 Jul 2025 | 2025-Q3 | 10 | 98.44 | 1.94 | 98.84 | +0.40 | |
| HJ-2507-P3062 | L-Glutathione (reduced) | 20 Jul 2025 | 2025-Q4 | 14 | 98.93 | 1.64 | 99.34 | +0.41 | |
| HJ-2507-E3085 | Semaglutide | 10 Jul 2025 | 2025-Q3 | 6 | 99.66 | 0.58 | 99.90 | +0.24 | |
| HJ-2507-V3160 | Epitalon | 09 Jul 2025 | 2025-Q4 | 1 | 98.77 | n<2 | 99.78 | +1.01 | SHARED BULK |
| HJ-2505-H3571 | Tirzepatide | 30 May 2025 | 2025-Q2 | 2 | 98.66 | 0.20 | 98.97 | +0.31 | |
| HJ-2504-X2985 | Ipamorelin | 23 Apr 2025 | 2025-Q3 | 11 | 99.63 | 1.02 | 99.90 | +0.27 | |
| HJ-2504-Y4203 | Semaglutide | 18 Apr 2025 | 2025-Q2 | 8 | 98.85 | 1.34 | 99.08 | +0.23 | |
| HJ-2503-M3890 | GHK-Cu | 24 Mar 2025 | 2025-Q3 | 1 | 99.93 | n<2 | 99.35 | -0.58 | |
| HJ-2503-M3088 | BPC-157 | 08 Mar 2025 | 2025-Q3 | 3 | 99.93 | 0.00 | 99.90 | -0.03 | |
| HJ-2502-P3591 | Tirzepatide | 13 Feb 2025 | 2025-Q1 | 5 | 99.12 | 1.27 | 99.81 | +0.69 | |
| HJ-2502-E4073 | AOD-9604 | 12 Feb 2025 | 2025-Q1 | 4 | 98.13 | 0.75 | 98.84 | +0.71 | |
| HJ-2502-U2908 | TB-500 | 11 Feb 2025 | 2025-Q3 | 1 | 99.41 | n<2 | 100.50 | +1.09 | SHARED BULK |
| HJ-2501-G2609 | MK-677 (Ibutamoren mesylate) | 24 Jan 2025 | 2025-Q2 | 1 | 99.11 | n<2 | 99.90 | +0.79 | |
| HJ-2501-P2892 | Tirzepatide | 21 Jan 2025 | 2025-Q1 | 12 | 98.16 | 1.88 | 99.04 | +0.88 | |
| HJ-2501-M3464 | Selank | 19 Jan 2025 | 2025-Q1 | 1 | 99.57 | n<2 | 99.90 | +0.33 | |
| HJ-2501-A3383 | TB-500 | 02 Jan 2025 | 2025-Q1 | 6 | 99.38 | 0.96 | 99.85 | +0.47 | |
| HJ-2412-G3929 | GHRP-2 | 31 Dec 2024 | 2025-Q1 | 14 | 99.24 | 1.54 | 99.79 | +0.55 | |
| HJ-2412-C3784 | Retatrutide | 05 Dec 2024 | 2025-Q2 | 4 | 97.62 | 0.72 | 98.50 | +0.88 | |
| HJ-2412-V4024 | AOD-9604 | 03 Dec 2024 | 2025-Q2 | 3 | 99.06 | 0.68 | 99.71 | +0.65 | |
| HJ-2411-D4299 | Retatrutide | 25 Nov 2024 | 2025-Q1 | 8 | 99.05 | 1.32 | 99.05 | 0.00 | |
| HJ-2411-R4154 | TB-500 | 22 Nov 2024 | 2025-Q1 | 1 | 99.44 | n<2 | 99.90 | +0.46 | |
| HJ-2411-M2763 | Retatrutide | 20 Nov 2024 | 2024-Q4 | 3 | 98.28 | 0.73 | 98.08 | -0.20 | |
| HJ-2410-G2561 | IGF-1 LR3 | 01 Oct 2024 | 2025-Q1 | 6 | 97.86 | 0.73 | 98.23 | +0.37 | |
| HJ-2407-D4137 | BPC-157 | 20 Jul 2024 | 2024-Q4 | 8 | 99.84 | 0.73 | 99.90 | +0.06 | |
| HJ-2405-C4622 | AOD-9604 | 16 May 2024 | 2024-Q3 | 1 | 98.83 | n<2 | 99.17 | +0.34 | |
| HJ-2402-M3127 | BPC-157 | 29 Feb 2024 | 2024-Q2 | 4 | 99.46 | 0.75 | 99.64 | +0.18 | |
| HJ-2309-J4137 | Retatrutide | 16 Sep 2023 | 2024-Q1 | 8 | 98.91 | 1.10 | 99.50 | +0.59 |